!!!ISRAELI_SON

SoniVie raised $2.5M from Accelmed

November 3, 2015 • DEALS

SoniVie, a company that is developing a system for the treatment of pulmonary arterial hypertension, recently raised an additional 2.5 million dollars from Israeli bio-medical fund Accelmed. With the new capital, SoniVie will fund the first in vivo trials for the treatment of pulmonary arterial hypertension, a severe disease that narrows the blood vessels connected to and within the lungs.

Tags

Accelmed, SoniVie
Pin It

Related Posts